biote Corp. (BTMD)

NASDAQ: BTMD · IEX Real-Time Price · USD
5.52
-0.19 (-3.33%)
Apr 17, 2024, 4:00 PM EDT - Market closed
-3.33%
Market Cap 411.41M
Revenue (ttm) 185.36M
Net Income (ttm) 3.32M
Shares Out 74.53M
EPS (ttm) 0.13
PE Ratio 42.46
Forward PE 16.74
Dividend n/a
Ex-Dividend Date n/a
Volume 62,713
Open 5.69
Previous Close 5.71
Day's Range 5.50 - 5.69
52-Week Range 3.65 - 8.22
Beta 0.87
Analysts Strong Buy
Price Target 8.11 (+46.92%)
Earnings Date May 7, 2024

About BTMD

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; p... [Read more]

Sector Healthcare
Founded 2012
Employees 194
Stock Exchange NASDAQ
Ticker Symbol BTMD
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for BTMD stock is "Strong Buy." The 12-month stock price forecast is $8.11, which is an increase of 46.92% from the latest price.

Price Target
$8.11
(46.92% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

This overlooked corner of women's health could be a $350 billion market opportunity

Menopause is among the female health conditions with the highest unmet need and has 'enormous potential for innovative treatments,' according to McKinsey.

Other symbols: PFEPGNYVTGNDARE
4 weeks ago - CNBC

Biote Reports Fourth Quarter and Full Year 2023 Financial Results

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today a...

5 weeks ago - Business Wire

Biote Schedules Fourth Quarter and Full Year 2023 Financial Results Release and Conference Call

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

7 weeks ago - Business Wire

Biote Announces Agreement to Resolve Litigation and Repurchase All of Founder's Shares

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

2 months ago - Business Wire

Biote Announces $20 Million Share Repurchase Authorization

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

2 months ago - Business Wire

Biote to Purchase Asteria Health

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

3 months ago - Business Wire

Biote Provides Preliminary 2023 Results and Initial 2024 Guidance

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

3 months ago - Business Wire

Biote Names Robert Peterson as Chief Financial Officer

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

3 months ago - Business Wire

Biote Reports Third Quarter 2023 Financial Results

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced financial results for...

5 months ago - Business Wire

Biote Schedules Third Quarter 2023 Financial Results Release and Conference Call

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading provider of hormone optimization, today announced the Company will provide third quarter financial resu...

6 months ago - Business Wire

Biote Reports Second Quarter 2023 Financial Results

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced financial results for...

8 months ago - Business Wire

Biote Schedules Second Quarter 2023 Financial Results Release and Conference Call

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading provider of hormone optimization, today announced the Company will provide second quarter financial res...

9 months ago - Business Wire

Biote Formalizes Commitment to Men's Hormone Health With Launch of New Men's Health Division

IRVING, Texas--(BUSINESS WIRE)---- $BTMD #antiaging--Biote, a leading provider of hormone optimization, has announced the launch of a dedicated Men's Health Division.

10 months ago - Business Wire

Biote Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD) (the “Company,” “we” or “us”), a leading solutions provider in preventive healthcare through the delivery of personalized hormone therapy, today an...

11 months ago - Business Wire

Biote Announces Pricing of Secondary Offering of Common Stock

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading provider of preventive health care through the delivery of personalized hormone therapy, today announce...

11 months ago - Business Wire

Biote to Participate at Upcoming Investor Conferences

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, toda...

11 months ago - Business Wire

Biote Appoints Mary J. Puncochar as Chief Commercial Officer

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, toda...

11 months ago - Business Wire

Biote Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD) (the “Company,” “we” or “us”), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today a...

1 year ago - Business Wire

Biote Reports First Quarter 2023 Financial Results

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced financial results for...

1 year ago - Business Wire

Biote Schedules First Quarter 2023 Financial Results Release and Conference Call

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading provider of preventive health care through the delivery of personalized hormone therapy, today announce...

1 year ago - Business Wire

Biote Names John Denne as General Manager, Men's Health Division

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced that John Denne has j...

1 year ago - Business Wire

Biote Reports Fourth Quarter and Full Year 2022 Financial Results

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced financial results for...

1 year ago - Business Wire

Study: Testosterone Pellet Therapy Significantly Improves Bone Density in Male Patient Case Report

IRVING, Texas--(BUSINESS WIRE)---- $BTMD #antiaging--In a case study, a 54-year-old male patient with a spontaneous fracture and osteoporosis achieved an “almost complete recovery of osteoporosis” aft...

1 year ago - Business Wire

Biote to Present at 35th Annual Roth Conference

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading innovator in preventive health care through the delivery of personalized hormone therapy, today announc...

1 year ago - Business Wire

Biote Schedules Fourth Quarter and Full Year 2022 Financial Results Release and Conference Call

IRVING, Texas--(BUSINESS WIRE)--Biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading provider of preventive health care through the delivery of personalized hormone therapy, today announce...

1 year ago - Business Wire